Viemed Healthcare (NASDAQ:VMD) Stock Rating Upgraded by Wall Street Zen

Viemed Healthcare (NASDAQ:VMD) was upgraded by equities research analysts at Wall Street Zen from a “buy” rating to a “strong-buy” rating in a research report issued to clients and investors on Saturday, Wall Street Zen reports.

Other analysts have also recently issued reports about the stock. Barrington Research initiated coverage on shares of Viemed Healthcare in a report on Monday, August 24th. They set an “outperform” rating and a $14.00 target price for the company. Freedom Capital cut Viemed Healthcare from a “strong-buy” rating to a “hold” rating in a report on Wednesday, August 5th. Finally, Weiss Ratings downgraded Viemed Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Monday, August 17th. One analyst has rated the stock with a Buy rating and three have given a Hold rating to the stock. According to MarketBeat.com, Viemed Healthcare has an average rating of “Hold” and a consensus target price of $14.00.

Viemed Healthcare Stock Performance

Shares of NASDAQ VMD opened at $9.13 on Friday. The stock has a fifty day moving average price of $9.26 and a two-hundred day moving average price of $9.59. The company has a debt-to-equity ratio of 0.05, a quick ratio of 1.16 and a current ratio of 1.25. The firm has a market cap of $345.96 million, a P/E ratio of 24.03, a PEG ratio of 2.21 and a beta of 1.05. Viemed Healthcare has a 1 year low of $6.18 and a 1 year high of $12.61.

Viemed Healthcare (NASDAQ:VMD) last posted its quarterly earnings data on Wednesday, November 4th. The company reported $0.11 EPS for the quarter, missing analysts’ consensus estimates of $0.12 by ($0.01). Viemed Healthcare had a return on equity of 10.64% and a net margin of 5.03%. The firm had revenue of $80.67 million during the quarter, compared to the consensus estimate of $80.78 million. Research analysts forecast that Viemed Healthcare will post 0.41 EPS for the current fiscal year.

Hedge Funds Weigh In On Viemed Healthcare

A number of institutional investors have recently bought and sold shares of the stock. Covestor Ltd purchased a new stake in shares of Viemed Healthcare in the 3rd quarter valued at approximately $28,000. Signaturefd LLC grew its position in Viemed Healthcare by 64.0% during the 3rd quarter. Signaturefd LLC now owns 4,939 shares of the company’s stock worth $45,000 after purchasing an additional 1,927 shares in the last quarter. State of Alaska Department of Revenue grew its position in Viemed Healthcare by 49.8% during the 3rd quarter. State of Alaska Department of Revenue now owns 5,145 shares of the company’s stock worth $46,000 after purchasing an additional 1,711 shares in the last quarter. Globeflex Capital L P purchased a new position in Viemed Healthcare during the 2nd quarter worth approximately $86,000. Finally, Legal & General Group Plc acquired a new stake in Viemed Healthcare during the 2nd quarter valued at $97,000. Hedge funds and other institutional investors own 74.24% of the company’s stock.

Viemed Healthcare Company Profile

Viemed Healthcare, Inc (NASDAQ: VMD) is a U.S. healthcare company that provides in-home medical equipment and clinical services for patients with chronic respiratory and other complex medical conditions. Its services are designed to help patients receive care at home while supporting hospitals and clinicians in managing ongoing conditions.

The company’s offerings include non-invasive ventilation, oxygen therapy, sleep-apnea equipment, respiratory therapy, remote patient monitoring and related durable medical equipment.